BrightSpring Q4 revenue $2.38B (+20.5%), net loss narrows to $7M; guides FY24 revenue $9.35-9.50B

BrightSpring Health Services, Inc.

2024-FY EPS reported -$1.31 revenue$8,826,175,000

Q4 revenue $2,375M (+20.5% YoY); gross profit $369M (15.5% of revenue).
Q4 net loss $7M ($0.06 per share) vs loss $56M ($0.48) in Q4 2022.
Full year 2023 net loss $155M ($1.31 per share) vs loss $54M ($0.46) in 2022.
Full year Adjusted EBITDA I $538M (+2.9%); Q4 Adjusted EBITDA I $143M (+2.5%).
FY2024 guidance: revenue $9,350-9,500M; Adj. EBITDA II $550-564M; excludes future acquisitions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BrightSpring Health Services, Inc. updated its fourth quarter and full year ended December 31, 2023 guidance (reaffirmed).

Period: fourth quarter and full year ended December 31, 2023
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On February 29, 2024, BrightSpring Health Services, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2023.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

BrightSpring Health Services, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-051727

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.